Shopping Cart 0
Cart Subtotal
AED 0

Osmotica Pharmaceutical Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such as formulation research and development, analytical development, bioanalytical development, clinical development and laser drilling technologies, among others. Osmotica primarily provides development of therapies for the treatment of central nervous system (CNS) disorders. The company provides portfolio of products which are in various stages of development focused on the treatment of movement disorders. It also has operational presence in Argentina and Hungary. Osmotica is headquartered in Marietta, Georgia, the US.

Osmotica Pharmaceutical Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11

Partnerships 13

Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13

Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14

Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15

Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16

Licensing Agreements 17

Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17

Equity Offering 18

Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18

Acquisition 19

Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19

Osmotica Pharmaceutical Corp-Key Competitors 20

Osmotica Pharmaceutical Corp-Key Employees 21

Osmotica Pharmaceutical Corp-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Joint Venture 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Key Facts 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Osmotica Pharmaceutical Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11

Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13

Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14

Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15

Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16

Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17

Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18

Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19

Osmotica Pharmaceutical Corp, Key Competitors 20

Osmotica Pharmaceutical Corp, Key Employees 21

Osmotica Pharmaceutical Corp, Other Locations 22

Osmotica Pharmaceutical Corp, Subsidiaries 22

Osmotica Pharmaceutical Corp, Joint Venture 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Osmotica Pharmaceutical Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Osmotica Pharmaceutical Corp (Osmotica) is a pharmaceutical company that specializes in drug delivery technologies and neurology based therapies. The company provides product portfolio such as nifedipine, oxybutynin, venlafaxine and desvenlafaxine, among others. It offers capabilities such as formulation research and development, analytical development, bioanalytical development, clinical development and laser drilling technologies, among others. Osmotica primarily provides development of therapies for the treatment of central nervous system (CNS) disorders. The company provides portfolio of products which are in various stages of development focused on the treatment of movement disorders. It also has operational presence in Argentina and Hungary. Osmotica is headquartered in Marietta, Georgia, the US.

Osmotica Pharmaceutical Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deal Details 11

Asset Purchase 11

Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11

Partnerships 13

Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13

Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14

Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15

Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16

Licensing Agreements 17

Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17

Equity Offering 18

Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18

Acquisition 19

Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19

Osmotica Pharmaceutical Corp-Key Competitors 20

Osmotica Pharmaceutical Corp-Key Employees 21

Osmotica Pharmaceutical Corp-Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Joint Venture 23

Appendix 24

Methodology 24

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Key Facts 2

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Osmotica Pharmaceutical Corp, Deals By Therapy Area, 2012 to YTD 2018 8

Osmotica Pharmaceutical Corp, Medical Devices Deals, 2012 to YTD 2018 9

Osmotica Pharmaceutical Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Vertical Pharma Acquires Portfolio Of Womens Health Products From Upsher-Smith Labs 11

Pernix Therapeutics Enters Into Co-Promotion Agreement With Osmotica Pharma For Khedezla ER Tablets 13

Vertcal Pharma Enters Into Co-Promotion Agreement With Poly Pharma For Zonatuss 14

Nautilus Neurosciences Enters Into Co-Promotion Agreement With Vertical Pharma For Lorzone 15

Osmotica Pharma Enters Into R&D Agreement With Panacea Biotec For Brand And Generic Products 16

Osmotica Pharma Enters into Licensing Agreement with RevitaLid 17

Osmotica Pharma to Raise up to USD132.8 Million in IPO of Shares 18

Jubilant Acquires Remaining 17.6% Stake in Cadista for up to USD33.2 Million in Tender Offer 19

Osmotica Pharmaceutical Corp, Key Competitors 20

Osmotica Pharmaceutical Corp, Key Employees 21

Osmotica Pharmaceutical Corp, Other Locations 22

Osmotica Pharmaceutical Corp, Subsidiaries 22

Osmotica Pharmaceutical Corp, Joint Venture 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Osmotica Pharmaceutical Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.